Ligand validation:2LH3

HEM: PROTOPORPHYRIN IX CONTAINING FE

HEM is a Ligand Of Interest in 2LH3 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2LH3_HEM_A_155	30%	3%	0.183	0.847	3.88	2.32	29	20	2	0	100%	1
2LH7_HEM_A_154	32%	3%	0.161	0.831	3.8	2.35	30	20	7	0	100%	0.9302
1LH3_HEM_A_155	31%	2%	0.184	0.853	4.1	2.6	31	20	2	0	100%	1
1LH6_HEM_A_154	30%	2%	0.189	0.853	4.28	2.71	29	16	6	0	100%	0.9302
2LH6_HEM_A_154	30%	2%	0.19	0.853	4.08	2.53	30	20	2	0	100%	0.9302
1LH7_HEM_A_154	29%	2%	0.168	0.826	4.04	2.58	29	21	7	0	100%	0.9302
5YCE_HEM_A_201	100%	37%	0.036	0.997	1.14	1.34	2	6	1	0	100%	1
3M8M_HEM_A_396	100%	38%	0.035	0.995	1.09	1.34	3	6	0	0	100%	1
1GWE_HEM_A_504	100%	43%	0.041	0.998	0.98	1.21	1	6	0	0	100%	1
3X34_HEM_A_101	100%	28%	0.043	0.997	1.33	1.54	8	12	2	0	100%	0.8972
8IAG_HEM_B_301	100%	23%	0.04	0.992	1.7	1.5	4	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.